As a silent killer, hypertension contributes to the majority of cardiovascular events. At WCC 2026, this session will explore hypertension’s evolving pathophysiology, secondary causes, and pharmacologic as well as lifestyle management strategies. It will also examine renovascular hypertension, peripheral artery disease, and vascular anomalies. Attendees will gain insights into ambulatory BP monitoring, global disparities in control rates, and the future of personalized antihypertensive therapy.